Study ID: TVP-1012/PM103

Study Title

Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease

Teva Identifier

TVP-1012/PM103

ClinicalTrials.gov Identifier

NCT01049984

Study Status

Completed

Trial Condition(s)

Parkinson's Disease

Interventions

Drug: Rasagiline | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

30 Years and older

Trial Duration

12/01/2009 - 10/01/2012

Phase

Phase 4

Study Type

Interventional